Inventor · disambiguated record
Daniel K. Kirchhofer
Also filed as: KIRCHHOFER DANIEL · KIRCHHOFER DANIEL K
29 granted patents·33 pending applications·142 citations·filing 1993–2023
96Inventor score
Top patents by PatentIndex Score
62 records- 0192US6703494B2Anti-tissue factor antibodies with enhanced anticoagulant potencyGENENTECH INC·Filed 2001·Granted Mar 9, 2004·28 cites·19 claims
- 0291US10421822B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2018·Granted Sep 24, 2019·4 cites·52 claims
- 0391US7825221B2Antibodies that bind hepatocyte growth factor activatorGENENTECH INC·Filed 2008·Granted Nov 2, 2010·10 cites·11 claims
- 0487US7741096B2Crystal structure of hepatocyte growth factor activator complexed with Kunitz domain inhibitorGENENTECH INC·Filed 2005·Granted Jun 22, 2010·7 cites·14 claims
- 0587US7622265B2Methods and compositions for modulating prostasinGENENTECH INC·Filed 2006·Granted Nov 24, 2009·10 cites·11 claims
- 0686US2024067752A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2023·Application pending·0 cites
- 0785US10421821B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 24, 2019·2 cites·44 claims
- 0885US9266961B2Anti-PCSK9 antibodies, formulations, dosing, and methods of useGENENTECH INC·Filed 2013·Granted Feb 23, 2016·8 cites·42 claims
- 0984US6800604B2Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factorGENENTECH INC·Filed 2000·Granted Oct 5, 2004·15 cites·27 claims
- 1083US11512143B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2019·Granted Nov 29, 2022·1 cites·21 claims
- 1183US9738727B2Anti-HtrA1 antibodies and methods of useGENENTECH INC·Filed 2012·Granted Aug 22, 2017·6 cites·33 claims
- 1282US7432044B2Methods and compositions for modulating hepatocyte growth factor activationGENENTECH INC·Filed 2005·Granted Oct 7, 2008·10 cites·4 claims
- 1382US2023383008A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2022·Application pending·0 cites
- 1480US7737115B2HGF beta chain variantsGENENTECH INC·Filed 2006·Granted Jun 15, 2010·3 cites·17 claims
- 1579US7435413B2Anti-tissue factor antibodies with enhanced anticoagulant potencyGENENTECH INC·Filed 2003·Granted Oct 14, 2008·4 cites·17 claims
- 1677US7354585B2Methods of treating coagulapathic or thrombotic disordersGENENTECH INC·Filed 2006·Granted Apr 8, 2008·2 cites·15 claims
- 1776US8124352B2Methods and compositions for targeting HEPSINKIRCHHOFER DANIEL K·Filed 2007·Granted Feb 28, 2012·2 cites·16 claims
- 1873US8435511B2Anti-hepsin antibodies and methods using sameGANESAN RAJKUMAR·Filed 2010·Granted May 7, 2013·2 cites·19 claims
- 1971US9975963B2NSP4 inhibitors and methods of useGENENTECH INC·Filed 2016·Granted May 22, 2018·1 cites·12 claims
- 2071US8759491B2Modulators of hepatocyte growth factor activatorGANESAN RAJKUMAR·Filed 2010·Granted Jun 24, 2014·2 cites·16 claims
- 2171US2010040634A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2009·Application pending·0 cites
- 2267US2019054138A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2018·Application pending·0 cites
- 2366US2008195366A1Crystal structure of the hepatocyte growth factor and methods of useEIGENBROT CHARLES W·Filed 2008·Application pending·0 cites
- 2466US2015126448A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2014·Application pending·0 cites
- 2565US8969528B2Antibodies to hepatocyte growth factor activatorGENENTECH INC·Filed 2013·Granted Mar 3, 2015·0 cites·14 claims
- 2664US10787484B2Compositions and methods for treating cardiovascular diseaseGENENTECH INC·Filed 2018·Granted Sep 29, 2020·0 cites·73 claims
- 2764US2010113350A1Methods and compositions for modulating prostasinGENENTECH INC·Filed 2009·Application pending·0 cites
- 2862US11034725B2Compositions and methods for treating cardiovascular diseaseGENENTECH INC·Filed 2020·Granted Jun 15, 2021·0 cites·9 claims
- 2962US6624295B1Human anti-factor IX/IXa antibodiesGENENTECH INC·Filed 1999·Granted Sep 23, 2003·14 cites·8 claims
- 3061US2017106042A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2016·Application pending·0 cites
- 3160US2006035278A9Methods and compositions for modulating HGF/MetGENENTECH INC·Filed 2004·Application pending·0 cites
- 3260US2007129301A1Methods and compositions for modulating hgf/metKIRCHHOFER DANIEL K·Filed 2006·Application pending·0 cites
- 3358US2013143813A1Methods and compositions for modulating hgf/metKIRCHHOFER DANIEL K·Filed 2011·Application pending·0 cites
- 3458US2006003931A1Crystal structure of the hepatocyte growth factor and methods of useGENENTECH INC·Filed 2005·Application pending·0 cites
- 3558US2011177058A1Methods and compositions for modulating hgf/metGENENTECH INC·Filed 2010·Application pending·0 cites
- 3657US8399629B2Antibody modulators of hepatocyte growth factor activatorKIRCHHOFER DANIEL K·Filed 2010·Granted Mar 19, 2013·0 cites·11 claims
- 3757US2006147451A1Modulators of hepatocyte growth factor activatorGENENTECH INC·Filed 2005·Application pending·0 cites
- 3856US2009075317A1Methods and compositions for modulating hepatocyte growth factor activationGENENTECH INC·Filed 2008·Application pending·0 cites
- 3956US2013034570A1Methods and compositions for modulating prostasinGENENTECH INC·Filed 2012·Application pending·0 cites
- 4055US10246519B2NSP4 inhibitors and methods of useGENENTECH INC·Filed 2018·Granted Apr 2, 2019·0 cites·34 claims
- 4155US8383123B2Method of treatment targeting HEPSINGENENTECH INC·Filed 2012·Granted Feb 26, 2013·0 cites·7 claims
- 4255US7049411B2Human anti-factor IX/IXa antibodiesGENENTECH INC·Filed 2003·Granted May 23, 2006·0 cites·20 claims
- 4355US2019016826A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USEGENENTECH INC·Filed 2018·Application pending·0 cites
- 4453US2010061996A1Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activatorGENENTECH INC·Filed 2007·Application pending·0 cites
- 4553US2013022611A1Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activatorGENENTECH INC·Filed 2012·Application pending·0 cites
- 4652US2004132660A1Novel inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularizationGENENTECH INC·Filed 2003·Application pending·0 cites
- 4752US2017342163A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USEGENENTECH INC·Filed 2017·Application pending·0 cites
- 4849US2003143225A1Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agentsGENENTECH INC·Filed 2002·Application pending·0 cites
- 4948US8110377B2HGF β chain variantsKIRCHHOFER DANIEL K·Filed 2010·Granted Feb 7, 2012·0 cites·22 claims
- 5048US2014212431A1Pcsk9-binding polypeptides and methods of useGENENTECH INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Daniel K. Kirchhofer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →